Clelia Camassa

Clelia Camassa is an experienced professional in quality assurance and operations within the pharmaceutical industry. Currently serving as Quality Operations Director at Catalent Pharma Solutions since January 2020, Clelia has previously held various significant roles at Bristol-Myers Squibb from December 2003 to January 2020, including Quality Assurance Manager and Perfalgan Business Unit Leader. Clelia's expertise encompasses process deviation management, market complaints, lot release, and annual product reviews. Earlier experience at GlaxoSmithKline involved managing GMP documentation and internal-external auditing in quality assurance. Clelia holds a degree in Chemistry from Università degli Studi di Perugia and a Master in Quality, Safety, and Environment from Uninform & ANGQ Roma.